Yamamoto N - Search Results

1

Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus.

Yamamoto N, Urade M. Yamamoto N, et al. Microbes Infect. 2005 Apr;7(4):674-81. doi: 10.1016/j.micinf.2005.01.015. Epub 2005 Mar 22. Microbes Infect. 2005. PMID: 15848273 Free article.

2

Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus Type 1.

Yamamoto N. Yamamoto N. AIDS Res Hum Retroviruses. 2006 Mar;22(3):262-71. doi: 10.1089/aid.2006.22.262. AIDS Res Hum Retroviruses. 2006. PMID: 16545013

3

Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.

Toyohara Y, Hashitani S, Kishimoto H, Noguchi K, Yamamoto N, Urade M. Toyohara Y, et al. Among authors: yamamoto n. Oncol Lett. 2011 Jul;2(4):685-691. doi: 10.3892/ol.2011.306. Epub 2011 May 13. Oncol Lett. 2011. PMID: 22848250 Free PMC article.

4

Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF).

Yamamoto N, Suyama H, Yamamoto N, Ushijima N. Yamamoto N, et al. Int J Cancer. 2008 Jan 15;122(2):461-7. doi: 10.1002/ijc.23107. Int J Cancer. 2008. Retraction in: Int J Cancer. 2014 Sep 15;135(6):1509. PMID: 17935130 Retracted.

5

Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.

Yamamoto N, Suyama H, Nakazato H, Yamamoto N, Koga Y. Yamamoto N, et al. Cancer Immunol Immunother. 2008 Jul;57(7):1007-16. doi: 10.1007/s00262-007-0431-z. Cancer Immunol Immunother. 2008. Retraction in: Cancer Immunol Immunother. 2014 Dec;63(12):1349. doi: 10.1007/s00262-014-1616-x. PMID: 18058096 Free PMC article. Retracted.

6

Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF).

Yamamoto N, Ushijima N, Koga Y. Yamamoto N, et al. J Med Virol. 2009 Jan;81(1):16-26. doi: 10.1002/jmv.21376. J Med Virol. 2009. Retraction in: J Med Virol. 2014 Nov;86(11):1998. doi: 10.1002/jmv.24060. PMID: 19031451 Retracted.

7

Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.

Yamamoto N, Suyama H, Yamamoto N. Yamamoto N, et al. Transl Oncol. 2008 Jul;1(2):65-72. doi: 10.1593/tlo.08106. Transl Oncol. 2008. PMID: 18633461 Free PMC article.

8

Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis.

Kanda S, Mochizuki Y, Miyata Y, Kanetake H, Yamamoto N. Kanda S, et al. Among authors: yamamoto n. J Natl Cancer Inst. 2002 Sep 4;94(17):1311-9. doi: 10.1093/jnci/94.17.1311. J Natl Cancer Inst. 2002. PMID: 12208896

9

Sex differences in circulating microRNA profiles in heart failure with preserved and reduced ejection fraction.

Numata G, Nakamura S, Tokiwa H, Taguchi A, Toyoda M, Kohno T, Maki H, Shiraishi Y, Takeuchi S, Goda A, Daigo K, Yamamoto N, Adachi Y, Yabe K, Kato T, Hiroi Y, Kato N, Kawahara T, Ueda K, Amiya E, Hatano M, Fujita H, Ieda M, Sasano T, Takeda N, Kohro T, Hirota Y, Komuro I, Wada Y, Takimoto E. Numata G, et al. Among authors: yamamoto n. Eur Heart J Open. 2026 May 13;6(3):oeag073. doi: 10.1093/ehjopen/oeag073. eCollection 2026 May. Eur Heart J Open. 2026. PMID: 42282063 Free PMC article.

10

150-GHz wide-bandwidth balanced photodetector for high-baud-rate PSK signal detection.

Umezawa T, Matsumoto A, Akahane K, Yamamoto N. Umezawa T, et al. Among authors: yamamoto n. Opt Express. 2026 May 4;34(9):16723-16737. doi: 10.1364/OE.596896. Opt Express. 2026. PMID: 42271730 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,856 results

Search Page

Filters